Durvalumab after chemoradiotherapy in stage III non-small cell lung cancer - Aix-Marseille Université Access content directly
Journal Articles Journal of Thoracic Disease Year : 2018

Dates and versions

hal-02143672 , version 1 (29-05-2019)

Identifiers

Cite

Pascale Tomasini, Laurent Greillier, Arnaud Boyer, Arnaud Jeanson, Fabrice Barlesi. Durvalumab after chemoradiotherapy in stage III non-small cell lung cancer. Journal of Thoracic Disease, 2018, 10 (9), pp.S1032-S1036. ⟨10.21037/jtd.2018.04.61⟩. ⟨hal-02143672⟩

Collections

CNRS UNIV-AMU CRCM
22 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More